1.  17
    Characterisation of Organisational Issues in Paediatric Clinical Ethics Consultation: A Qualitative Study.D. J. Opel, B. S. Wilfond, D. Brownstein, D. S. Diekema & R. A. Pearlman - 2009 - Journal of Medical Ethics 35 (8):477-482.
    Background: The traditional approach to resolving ethics concerns may not address underlying organisational issues involved in the evolution of these concerns. This represents a missed opportunity to improve quality of care “upstream”. The purpose of this study was to understand better which organisational issues may contribute to ethics concerns. Methods: Directed content analysis was used to review ethics consultation notes from an academic children’s hospital from 1996 to 2006 (N = 71). The analysis utilised 18 categories of organisational issues derived (...)
    Direct download (4 more)  
    Export citation  
    Bookmark   13 citations  
  2. Enhancing Children Against Unhealthy Behaviors—An Ethical and Policy Assessment of Using a Nicotine Vaccine.O. Lev, B. S. Wilfond & C. M. McBride - 2013 - Public Health Ethics 6 (2):197-206.
    Health behaviors such as tobacco use contribute significantly to poor health. It is widely recognized that efforts to prevent poor health outcomes should begin in early childhood. Biomedical enhancements, such as a nicotine vaccine, are now emerging and have potential to be used for primary prevention of common diseases. In anticipation of such enhancements, it is important that we begin to consider the ethical and policy appropriateness of their use with children. The main ethical concerns raised by enhancing children relate (...)
    Direct download (10 more)  
    Export citation  
    Bookmark   2 citations  
  3.  10
    Case Vignette: Placebos and Informed Consent.J. Blustein, W. Robinson, G. S. Loeben & B. S. Wilfond - 1997 - Ethics and Behavior 8 (1):89-98.